ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
BPC-157/TB-500 Dosing
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="BigTex" data-source="post: 234674" data-attributes="member: 43589"><p>Lets say the injury is about a square inch. I would inject at the 4 corners. If the dose is 600mcg, i would inject 150mcg in each area. I also use 1 ml of BW to reconstitute a 5mg, vial of BPC 157. So each line on the syringe (1ml/100 lines) is 50mcg. 10 lines would be equal to the 600mg dose and 3 lines would equal 150mcg which I would inject in each corner. So it is not very much liquid.</p></blockquote><p></p>
[QUOTE="BigTex, post: 234674, member: 43589"] Lets say the injury is about a square inch. I would inject at the 4 corners. If the dose is 600mcg, i would inject 150mcg in each area. I also use 1 ml of BW to reconstitute a 5mg, vial of BPC 157. So each line on the syringe (1ml/100 lines) is 50mcg. 10 lines would be equal to the 600mg dose and 3 lines would equal 150mcg which I would inject in each corner. So it is not very much liquid. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
BPC-157/TB-500 Dosing
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top